FundedIQ
Health Care

Charles.co

Charles helps men regain control over their daily health concerns by starting with their personal health.

www.charles.co Paris, France 11-50 employees
Total raised
$300k
Rounds
1
Latest
Series Unknown
Mar 2026

Charles helps men regain control over their daily health concerns by starting with their personal health.

Charles.co has raised $300k across 1 round. Its most recent round was a Series Unknown of $300k in Mar 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Mar 1, 2026
Series Unknown
$300k

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Charles.co is featured in

Similar companies

Beams

Beams is a producer of medical devices for cancerology based on the use of particles β.

Series Unknown $1.7M
Padoa

Padoa is an occupational health software firm that develops a tool for monitoring the health of employees. Its service provides occupational health teams with a host of tools ranging from managing appointments, general administration, staff management, individual employee follow-ups, and the design of prevention policies in the workplace. The company aims to improve the health of millions of workers by applying innovation and technology to occupational health. It was founded in 2016 and is based in

Series Unknown
CILcare

CILcare specializes in providing drug solutions for hearing and ear disorders.

Series Unknown
Median Technologies

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.

Series Unknown $58.1M
Noa

noa is a digital fitness and wellness company that offers premium, structured training programs for strength, pilates, and overall well-being through expert coaching and technology-driven experiences.

Seed $5.8M
Semeia

Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in consultation. They use deep learning technologies to estimate the risk of the occurrence of an adverse event or disruption in the patients care pathway.

Series Unknown $24.7M
Signadori Bio

Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.

Seed $13.0M
Axomove

Axomove is an e-wellbeing application that spends significant time in video actual activities.

Series A $4.7M
Parallel 1245

Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate medical coding.

Series A $20.0M
May Health

May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is aimed at giving patients a more natural and less medicalized approach to pregnancy. Their goal is to help PCOS patients regain ovulation through a one-time, minimally invasive treatment that can be done in a clinic setting without the need for general anesthesia. The procedure is performed transvaginally under ultrasound guidance, using the same minimally invasive approach commonly used for IVF by fertility specialists.

Series Unknown $11.6M
MedinCell

MedinCell is an injectable slow-release drug specialist company.

Series Unknown $55.7M
Lifeaz

Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators.

Seed $15.4M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.